Differences in progression to AIDS between injection drug users and homosexual men with documented dates of seroconversion

Epidemiology

Volumn 7, Issue 6, 1996, Pages 571-577

  Spijkerman, Ingrid J B ^a   Langendam, Miranda W ^a   Veugelers, Paul J ^a   Van Ameijden, Erik J C ^a   Keet, Ireneus P M ^a   Geskus, Ronald B ^a   Van Hoek, Anneke Den ^a   Coutinho, Roel A ^a  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

Author keywords

cofactors; homosexual men; injection drug users; progression to AIDS

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG USE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCUBATION TIME; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; NETHERLANDS; PRIORITY JOURNAL; SEROCONVERSION;

EID: 0029851031     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-199611000-00002     Document Type: Article

References (34)

1. Veugelers PJ, Page KA, Tindall B, Schechter MT, Moss AR, Winkelstein W, Cooper DA, Craib KJP, Charlebois E, Coutinho RA, van Griensven GJP. Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study. Am J Epidemiol 1994;140:747-758.
2. Hessol NA, Koblin BA, van Griensven GJP, Bacchetti P, Liu JY, Stevens CE, Coutinho RA, Buchbinder SP, Katz MH. Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991. Am J Epidemiol 1994;139:1077-1087.
3. Muñoz A, Wang M, Bass S, Taylor JMG, Kingsley LA, Chmiel JS, Polk BF. Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Am J Epidemiol 1989;130:530-539.
4. Jason J, Lui K, Ragni MV, Hessol NA, Darrow WW. Risk of developing AIDS in HIV-infected cohorts of hemophilic and homosexual men. JAMA 1989;261:725-727.
5. Lee CA, Phillips AN, Elford J, Janossy G, Griffiths P, Kernoff P. Progression of HIV disease in a haemophilic cohort followed for 11 years and the effect of treatment. BMJ 1991;303:1093-1096.
6. Sabin C, Phillips A, Elford J, Griffiths P, Janossay G, Lee C. The progression of HIV disease in a haemophilic cohort followed for 12 years. Br J Haematol 1993;83:330-333.
7. The Italian Seroconversion Study. Disease progression and early predictors of AIDS in HIV-seroconverted injecting drug users. AIDS 1992;6:421-426.
8. Muñoz A, Vlahov D, Solomon L, Margolick JB, Bareta JC, Cohn S, Astemborski J, Nelson KE. Prognostic indicators for development of AIDS among intravenous drug users. J Acquir Immune Defic Syndr 1992;5: 694-700.
9. Rezza G, Lazzarin A, Angarano G, Sinicco A, Pristera R, Ortona L, Barbanera M, Gafa S, Tirelli U, Salassa B, Ricchi E, Aiuti F, Menniti-Ippolito F. The natural history of HIV infection in intravenous drug users: risk of disease progression in a cohort of seroconverters. AIDS 1989;3:87-90.
10. Alcabes P, Muñoz A, Vlahov D, Friedland G. Maturity of human immunodeficiency virus infection and incubation period of acquired immunodeficiency syndrome in injecting drug users. Ann Epidemiol 1994;4:17-26.
11. Multicohort Analysis Project Workshop. Part I. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. AIDS 1994;8:911-921.
12. Biggar RJ. AIDS incubation in 1891 HIV seroconverters from different exposure groups. International Registry of Seroconverters. AIDS 1990;4: 1059-1066.
13. Gauvreau K, De Gruttola V, Pagano M. Markers and incubation time: the effect of covariates on the induction time of AIDS using improved imputation of exact serovonversion time. Stat Med 1994;13:2021-2030.
14. Mariotto AB, Mariotti S, Pezzotti P, Rezza G, Verdecchia A. Estimation of the acquired immunodeficiency syndrome incubation period in intravenous drug users: a comparison with male homosexuals. Am J Epidemiol 1992;135: 428-437.
15. Vella S, Giuliano M, Floridia M, Chiesi A, Tomino C, Seeber A, Barcherini S, Bucciardini R, Mariotti S. Effect of sex, age and transmission category on the progression to AIDS and survival of zidovudine-treated symptomatic patients. AIDS 1995;9:51-56.
16. Cozzi Lepri A, Pezzotti P, Dorrucci M, Phillips AN, Rezza G. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. Italian Seroconversion Study. BMJ 1994;309:1537-1542.
17. Strathdee SA, Veugelers PJ, Moore PS. The epidemiology of HIV-associated Kaposi's sarcoma: the unraveling mystery. AIDS 1996;10(suppl A):S51-S57.
18. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41(No. RR-17)-17):1-19.
19. Mientjes GHC, van Ameijden EJC, Keet IPM, van Deutekom H, van den Hoek JAR, Coutinho RA. Disproportional impact of the revised AIDS surveillance definition on the AIDS incidence among drug users compared to homosexual men. Eur J Public Health 1995;5:288-290.
20. van Haastrecht HJA, van den Hoek JAR, Coutinho RA. High mortality among HIV-infected injecting drug users without AIDS-diagnosis: implications for HIV-infection epidemic modellers? AIDS 1994;8:363-366.
21. van Haastrecht HJA, van Ameijden EJC, van den Hoek JAR, Mientjes GHC, Bax JS, Coutinho RA. Predictors of mortality in the Amsterdam cohort of HIV-positive and HIV-negative drug users. Am J Epidemiol 1996;143:380-391.
22. van den Hoek JAR, Coutinho RA, van Haastrecht HJA, van Zadelhoff AW, Goudsmit J. Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS 1988;2:55-60.
23. van Griensven GJP, Tielman RAP, Goudsmit J, van der Noorda J, de Wolf F, de Vroome EMM, Coutinho RA. Risk factors and prevalence of HIV antibodies in homosexual men in the Netherlands. Am J Epidemiol 1987; 125:1048-1057.
24. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;36(suppl): 1S-15S.
25. Jongbloed G. The Iterative Convex Minorant Algorithm for Nonparametric Estimation (Technical Report). Delft, The Netherlands: Delft University of Technology, 1995.
26. Groeneboom P, Wellner JA. Information Bounds and Non Parametric Maximum Likelihood Estimation. Berlin: Birkhäuser Verlag, 1992.
27. Statistics and Epidemiology Research Corporation. EGRET User's Manual. Seattle: Statistics and Epidemiology Research Corporation, 1992.
28. Ancelle-Park R. Expanded European AIDS case definition (Letter). Lancet 1993;341:441.
29. Mientjes GHC, Miedema F, van den Hoek JAR, Coutinho RA. Immunologic alterations in splenectomized HIV-infected intravenous drug users. AIDS 1994;8:269-271.
30. Carré N, Deveau C, Belanger F, Boufassa F, Persoz A, Jadand C, Rouzioux C, Delfraissy JF, Bucquet D. Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. SEROCO Study Group. AIDS 1994;8:797-802.
31. Selwyn PA, Alcabes P, Hartel D, Buono D, Schoenbaum EE, Klein RS, Davenny K, Friedland GH. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. N Engl J Med 1992;327:1697-1703.
32. Farizo KM, Buehler JW, Chamberland ME, Whyte BM, Sivarajan Froelicher E, Hopkins SG, Reed CM, Mokotoff ED, Cohn DL, Troxler S, Phelps AF, Berkelman RL. Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA 1992;267:1798-1805.
33. Galai N, Vlahov D, Margolick JB, Chen K, Graham NMH, Muñoz A. Changes in markers of disease progression in HIV-1 seroconverters: a comparison between cohorts of injecting drug users and homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:66-74.
34. Margolick JB, Muñoz A, Vlahov D, Astemborski J, Solomon L, He XY, Nelson KE, Saah AJ. Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users. Arch Intern Med 1994;154:869-875.